Details for New Drug Application (NDA): 021501
✉ Email this page to a colleague
The generic ingredient in CAPITAL SOLEIL 15 is avobenzone; ecamsule; octocrylene. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the avobenzone; ecamsule; octocrylene profile page.
Summary for 021501
Tradename: | CAPITAL SOLEIL 15 |
Applicant: | Loreal Usa |
Ingredient: | avobenzone; ecamsule; octocrylene |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | CREAM;TOPICAL | Strength | 2%;3%;10% | ||||
Approval Date: | Oct 2, 2006 | TE: | RLD: | Yes |
Complete Access Available with Subscription